UBC Executive and Leadership Team

Bekki Brown, the President & Chief Executive Officer at UBC, directs the overarching strategy and operational execution for the organization. This leadership role involves guiding UBC's mission to make medicine and specialty therapies safer and more accessible by partnering with biopharmaceutical companies. Brown oversees the generation of real-world evidence, focusing on product effectiveness, safety, and value, particularly for rare diseases and novel indications. The Chief Executive Officer ensures that UBC's consultative approach, built on decades of epidemiological and operational experience, effectively supports healthcare decisions and enhances patient care throughout the product lifecycle. By driving the company's vision, Bekki Brown ensures tailored solutions are developed to assist products from phase II research through post-launch patient support and commercialization, solidifying UBC's market position in evidence-based research.

Steve Bell, the Chief Financial Officer & Acco Principal at UBC, manages the company's financial health and fiscal strategy. This executive oversees all financial operations, including budgeting, forecasting, and financial reporting, ensuring robust fiscal management across the organization. Bell's responsibilities extend to optimizing financial performance and resource allocation to support UBC's strategic objectives of enhancing medicine accessibility and safety. The Chief Financial Officer & Acco Principal plays a critical part in evaluating investment opportunities and managing financial risks associated with supporting biopharmaceutical companies. By maintaining financial integrity, Steve Bell ensures UBC can continue its specialized work in generating real-world evidence for rare diseases and specialty therapies, thereby supporting patient care and commercialization efforts throughout the product lifecycle.

Dean Reiman, the President at UBC, drives operational excellence and strategic initiatives across key business units. This leadership position focuses on enhancing the delivery of pharmaceutical support services, ensuring UBC's expertise in real-world evidence generation is effectively applied. Reiman oversees the implementation of tailored solutions that assist biopharmaceutical companies throughout the product lifecycle, from early research to post-launch support. The President plays a crucial role in fostering collaborations that make specialty therapies safer and more accessible to patients. By leveraging decades of epidemiological and operational experience, Dean Reiman ensures that UBC's consultative approach consistently supports healthcare decisions and improves patient care, reinforcing the company's commitment to evidence-based research and commercialization strategies.

Michael Haratz, the Senior Vice President, Chief Legal Officer at UBC, provides comprehensive legal counsel and oversees all legal affairs for the organization. This critical role involves managing corporate governance, regulatory compliance, and intellectual property matters, ensuring UBC operates within all legal frameworks. Haratz's expertise is vital in navigating the complex regulatory landscape of the biopharmaceutical industry, particularly concerning product safety and market access. The Chief Legal Officer advises on legal aspects of partnerships with biopharmaceutical companies and the generation of real-world evidence, safeguarding UBC's interests. By ensuring legal and ethical compliance, Michael Haratz supports the company's mission to make specialty therapies safer and more accessible, contributing to enhanced patient care and successful product commercialization.